Our FAQ page offers essential details about Chirayu Super Speciality Hospital's services, treatments, and appointment booking. Find answers to common questions about our specialized medical care, diagnostic tests, and treatment options. This resource ensures a smooth, informed experience when accessing our comprehensive healthcare services.
The Anti-Cardiolipin Antibody Test detects antibodies against cardiolipin, aiding in the diagnosis of antiphospholipid syndrome (APS) and evaluating the risk of blood clots.
A blood sample is collected from your arm and analyzed for the presence of anti-cardiolipin antibodies.
No special preparation or fasting is required. You can eat and drink normally before the test.
Results are typically available within 1-2 days, depending on the laboratory’s processing time.
Discuss any abnormal results with your healthcare provider for guidance on further tests or treatment options based on your specific condition.
High CPK-MB levels typically indicate heart muscle damage, such as from a heart attack.
Yes, certain medications can influence CPK-MB levels. It’s important to inform your healthcare provider about all medications you are taking.
No, fasting is not required for the CPK-MB test unless specified by your healthcare provider.
The frequency of testing depends on your health condition and your healthcare provider’s recommendations.
Abnormal CPK-MB levels may indicate heart muscle damage. Further evaluation and treatment will be necessary based on your test results.
The Sputum C/S Test identifies microorganisms causing respiratory infections and determines their sensitivity to antibiotics.
A sputum sample is collected by coughing up mucus from the lungs, usually in the morning for the best results.
No special preparation is needed, but it is important to follow hygiene practices and inform your healthcare provider of any recent treatments.
Results are generally available within 3 to 5 days, depending on the growth rate of the microorganisms and the complexity of the infection.
Discuss the results with your healthcare provider to determine alternative treatment options based on the sensitivity profile of the identified microorganisms.